Daniel Rader

2.3k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Daniel Rader is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Daniel Rader has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Cancer Research. Recurrent topics in Daniel Rader's work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Daniel Rader is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Daniel Rader collaborates with scholars based in United States. Daniel Rader's co-authors include Ivan S. Yuhanna, James A. de Lemos, Philip W. Shaul, Colby Ayers, Anand Rohatgi, Jarett D. Berry, Ian J. Neeland, Amit Khera, Hasan K. Siddiqi and Dániel Kiss and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Circulation Cardiovascular Quality and Outcomes.

In The Last Decade

Daniel Rader

8 papers receiving 1.1k citations

Hit Papers

HDL Cholesterol Efflux Capacity and Incident Cardiovascul... 2014 2026 2018 2022 2014 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Rader United States 4 658 589 274 224 165 9 1.1k
Menno Vergeer Netherlands 11 518 0.8× 437 0.7× 185 0.7× 164 0.7× 164 1.0× 15 869
Margaret R. Diffenderfer United States 21 923 1.4× 700 1.2× 272 1.0× 320 1.4× 257 1.6× 50 1.4k
Hal Kennedy United States 17 886 1.3× 613 1.0× 290 1.1× 320 1.4× 156 0.9× 21 1.3k
Martine Paquette Canada 21 721 1.1× 495 0.8× 428 1.6× 287 1.3× 191 1.2× 74 1.2k
Estelle Nobécourt France 17 604 0.9× 621 1.1× 179 0.7× 147 0.7× 262 1.6× 43 1.3k
Megan F. Burke United States 7 915 1.4× 812 1.4× 350 1.3× 301 1.3× 327 2.0× 9 1.7k
Carlo M. Barbagallo Italy 22 747 1.1× 503 0.9× 580 2.1× 173 0.8× 209 1.3× 100 1.6k
Allan D. Sniderman Canada 17 805 1.2× 733 1.2× 400 1.5× 245 1.1× 217 1.3× 37 1.5k
Roberto Scicali Italy 22 350 0.5× 474 0.8× 264 1.0× 134 0.6× 228 1.4× 51 1.2k
Amar A Sethi Denmark 20 833 1.3× 950 1.6× 550 2.0× 255 1.1× 340 2.1× 26 1.7k

Countries citing papers authored by Daniel Rader

Since Specialization
Citations

This map shows the geographic impact of Daniel Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rader more than expected).

Fields of papers citing papers by Daniel Rader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rader. The network helps show where Daniel Rader may publish in the future.

Co-authorship network of co-authors of Daniel Rader

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Rader. A scholar is included among the top collaborators of Daniel Rader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Rader. Daniel Rader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Doshi, Jalpa A., et al.. (2020). Abstract 285: Association Of Patient Out-of-pocket Costs And Financial Assistance With Prescription Abandonment: The Case Of PCSK9 Inhibitors. Circulation Cardiovascular Quality and Outcomes. 13(Suppl_1). 1 indexed citations
2.
Khera, Amit V., Connor A. Emdin, Isabel Drake, et al.. (2017). GENETIC RISK, ADHERENCE TO A HEALTHY LIFESTYLE, AND RISK OF CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 69(11). 2560–2560. 2 indexed citations
3.
Ferranti, Sarah D. de, Sarah Clauss, Irwin Benuck, et al.. (2017). Pediatric Familial Hypercholesterolemia: Children and Adolescents Enrolled in the CAscade SCreening for Awareness. Journal of clinical lipidology. 11(3). 812–813. 2 indexed citations
4.
Brewer, H B, Peter P. Tóth, Daniel Rader, & Jean‐Claude Tardif. (2015). The Role of HDL-C in the Management of Atherosclerosis. 2 indexed citations
5.
Siddiqi, Hasan K., Dániel Kiss, & Daniel Rader. (2015). HDL-cholesterol and cardiovascular disease. Current Opinion in Cardiology. 30(5). 536–542. 60 indexed citations
6.
Rohatgi, Anand, Amit Khera, Jarett D. Berry, et al.. (2014). HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events. New England Journal of Medicine. 371(25). 2383–2393. 1025 indexed citations breakdown →
7.
Aghili, Nima, Joseph M. Devaney, Muredach P. Reilly, et al.. (2012). POLYMORPHISMS IN DIPEPTIDYL PEPTIDASE IV GENE ARE ASSOCIATED WITH THE RISK OF MYOCARDIAL INFARCTION IN PATIENTS WITH ATHEROSCLEROSIS. Journal of the American College of Cardiology. 59(13). E1400–E1400. 13 indexed citations
8.
Dunbar, Richard L., LeAnne T. Bloedon, Rajesh Movva, et al.. (2009). Abstract: P471 IMPACT OF THE MTP-INHIBITOR AEGR-733 ON THE SINGLE-DOSE PHARMACOKINETICS OF EXTENDED-RELEASE NIACIN. Atherosclerosis Supplements. 10(2). e782–e782. 3 indexed citations
9.
Dunbar, Richard L., LeAnne T. Bloedon, Danielle Duffy, et al.. (2009). Abstract: P469 IMPACT OF HIGH DOSES OF THE MTP-INHIBITOR, AEGR-733, ON THE SINGLE DOSE PHARMACOKINETICS OF ATORVASTATIN AND ROSUVASTAIN. Atherosclerosis Supplements. 10(2). e780–e780. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026